

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | positive regulation of gamma-delta T cell activation (GO:0046645) | 5.17658863 |
| 2 | negative regulation of cell killing (GO:0031342) | 4.99058508 |
| 3 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 4.99058508 |
| 4 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 4.38740617 |
| 5 | regulation of B cell receptor signaling pathway (GO:0050855) | 4.37996150 |
| 6 | negative thymic T cell selection (GO:0045060) | 4.36594142 |
| 7 | negative T cell selection (GO:0043383) | 4.28244289 |
| 8 | interferon-gamma production (GO:0032609) | 4.27299864 |
| 9 | regulation of gamma-delta T cell differentiation (GO:0045586) | 4.22790032 |
| 10 | regulation of gamma-delta T cell activation (GO:0046643) | 4.11535394 |
| 11 | positive thymic T cell selection (GO:0045059) | 4.08571034 |
| 12 | activated T cell proliferation (GO:0050798) | 4.07639880 |
| 13 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 4.02764544 |
| 14 | tolerance induction (GO:0002507) | 4.02144938 |
| 15 | antigen processing and presentation of endogenous antigen (GO:0019883) | 3.94323780 |
| 16 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 3.88921955 |
| 17 | positive T cell selection (GO:0043368) | 3.85322913 |
| 18 | leukocyte aggregation (GO:0070486) | 3.68828560 |
| 19 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 3.67401161 |
| 20 | T cell selection (GO:0045058) | 3.65499837 |
| 21 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 3.64286313 |
| 22 | negative regulation of T cell mediated immunity (GO:0002710) | 3.59024649 |
| 23 | thymic T cell selection (GO:0045061) | 3.57899538 |
| 24 | positive regulation of B cell differentiation (GO:0045579) | 3.56519382 |
| 25 | response to interleukin-15 (GO:0070672) | 3.53710164 |
| 26 | positive regulation of granulocyte differentiation (GO:0030854) | 3.47772235 |
| 27 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 3.47621632 |
| 28 | cellular response to interleukin-15 (GO:0071350) | 3.35669385 |
| 29 | regulation of alpha-beta T cell proliferation (GO:0046640) | 3.34168146 |
| 30 | negative regulation of CD4-positive, alpha-beta T cell activation (GO:2000515) | 3.26481110 |
| 31 | B cell receptor signaling pathway (GO:0050853) | 3.23759006 |
| 32 | regulation of B cell differentiation (GO:0045577) | 3.14391869 |
| 33 | mucosal-associated lymphoid tissue development (GO:0048537) | 3.12275020 |
| 34 | Peyers patch development (GO:0048541) | 3.12275020 |
| 35 | regulation of T cell mediated cytotoxicity (GO:0001914) | 3.00798947 |
| 36 | negative regulation of leukocyte mediated immunity (GO:0002704) | 2.99839689 |
| 37 | T cell migration (GO:0072678) | 2.93601530 |
| 38 | positive regulation of alpha-beta T cell proliferation (GO:0046641) | 2.87862957 |
| 39 | positive regulation of T cell mediated cytotoxicity (GO:0001916) | 2.87745572 |
| 40 | negative regulation of erythrocyte differentiation (GO:0045647) | 2.86828627 |
| 41 | germinal center formation (GO:0002467) | 2.85495153 |
| 42 | regulation of T cell tolerance induction (GO:0002664) | 2.81154216 |
| 43 | defense response to protozoan (GO:0042832) | 2.76172866 |
| 44 | mast cell activation (GO:0045576) | 2.71888104 |
| 45 | antigen receptor-mediated signaling pathway (GO:0050851) | 2.70835148 |
| 46 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 2.68356592 |
| 47 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 2.68356592 |
| 48 | modulation by symbiont of host immune response (GO:0052553) | 2.68356592 |
| 49 | positive regulation by symbiont of host defense response (GO:0052509) | 2.68356592 |
| 50 | modulation by symbiont of host defense response (GO:0052031) | 2.68356592 |
| 51 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 2.68356592 |
| 52 | negative regulation of alpha-beta T cell activation (GO:0046636) | 2.66528488 |
| 53 | cellular extravasation (GO:0045123) | 2.65591896 |
| 54 | regulation of interleukin-2 biosynthetic process (GO:0045076) | 2.63916209 |
| 55 | negative regulation of adaptive immune response based on somatic recombination of immune receptors b | 2.62548937 |
| 56 | regulation of natural killer cell mediated cytotoxicity (GO:0042269) | 2.62024802 |
| 57 | regulation of natural killer cell mediated immunity (GO:0002715) | 2.62024802 |
| 58 | regulation of regulatory T cell differentiation (GO:0045589) | 2.61993340 |
| 59 | regulation of granulocyte differentiation (GO:0030852) | 2.61515489 |
| 60 | response to protozoan (GO:0001562) | 2.60762504 |
| 61 | detection of bacterium (GO:0016045) | 2.60221355 |
| 62 | T cell homeostasis (GO:0043029) | 2.60201702 |
| 63 | L-fucose catabolic process (GO:0042355) | 2.60032620 |
| 64 | fucose catabolic process (GO:0019317) | 2.60032620 |
| 65 | L-fucose metabolic process (GO:0042354) | 2.60032620 |
| 66 | cytidine metabolic process (GO:0046087) | 2.58512475 |
| 67 | cytidine catabolic process (GO:0006216) | 2.58512475 |
| 68 | cytidine deamination (GO:0009972) | 2.58512475 |
| 69 | regulation of alpha-beta T cell activation (GO:0046634) | 2.57968667 |
| 70 | regulation of CD4-positive, alpha-beta T cell activation (GO:2000514) | 2.57552211 |
| 71 | regulation of antigen receptor-mediated signaling pathway (GO:0050854) | 2.55788092 |
| 72 | regulation of tolerance induction (GO:0002643) | 2.55525430 |
| 73 | regulation of leukocyte mediated cytotoxicity (GO:0001910) | 2.55253794 |
| 74 | immunoglobulin mediated immune response (GO:0016064) | 2.53916533 |
| 75 | sulfation (GO:0051923) | 2.52773807 |
| 76 | pyrimidine ribonucleoside catabolic process (GO:0046133) | 2.52759025 |
| 77 | negative regulation of T-helper cell differentiation (GO:0045623) | 2.52503002 |
| 78 | negative regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043371) | 2.52503002 |
| 79 | negative regulation of interleukin-12 production (GO:0032695) | 2.51041880 |
| 80 | negative regulation of adaptive immune response (GO:0002820) | 2.50521944 |
| 81 | negative regulation of interleukin-6 production (GO:0032715) | 2.50488236 |
| 82 | positive regulation of CD4-positive, alpha-beta T cell activation (GO:2000516) | 2.50395646 |
| 83 | protein K11-linked deubiquitination (GO:0035871) | 2.49931348 |
| 84 | regulation of T cell cytokine production (GO:0002724) | 2.49654219 |
| 85 | regulation of isotype switching to IgG isotypes (GO:0048302) | 2.49530248 |
| 86 | alpha-beta T cell differentiation (GO:0046632) | 2.46251690 |
| 87 | positive regulation of calcium-mediated signaling (GO:0050850) | 2.45731377 |
| 88 | negative regulation of innate immune response (GO:0045824) | 2.45228844 |
| 89 | regulation of T cell mediated immunity (GO:0002709) | 2.45198845 |
| 90 | positive regulation of T cell differentiation in thymus (GO:0033089) | 2.43175848 |
| 91 | leukocyte degranulation (GO:0043299) | 2.43163117 |
| 92 | detection of other organism (GO:0098543) | 2.43098284 |
| 93 | negative regulation of protein oligomerization (GO:0032460) | 2.42405259 |
| 94 | purinergic nucleotide receptor signaling pathway (GO:0035590) | 2.42266203 |
| 95 | mast cell degranulation (GO:0043303) | 2.42128824 |
| 96 | mast cell activation involved in immune response (GO:0002279) | 2.42128824 |
| 97 | regulation of mast cell activation (GO:0033003) | 2.41739936 |
| 98 | alpha-beta T cell activation (GO:0046631) | 2.41652549 |
| 99 | neutrophil activation involved in immune response (GO:0002283) | 2.40765960 |
| 100 | positive regulation of mast cell activation (GO:0033005) | 2.39668129 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 4.94793147 |
| 2 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 3.83325720 |
| 3 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 3.12321105 |
| 4 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 3.06664000 |
| 5 | RUNX_20019798_ChIP-Seq_JUKART_Human | 2.75078480 |
| 6 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 2.52232327 |
| 7 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 2.37016113 |
| 8 | EZH2_22144423_ChIP-Seq_EOC_Human | 2.33389133 |
| 9 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 2.15292579 |
| 10 | DROSHA_22980978_ChIP-Seq_HELA_Human | 2.09336849 |
| 11 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 2.09315089 |
| 12 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 2.08357007 |
| 13 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 2.07721408 |
| 14 | MYB_26560356_Chip-Seq_TH2_Human | 1.96793555 |
| 15 | ZNF274_21170338_ChIP-Seq_K562_Hela | 1.95694389 |
| 16 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.92916914 |
| 17 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.91188182 |
| 18 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.82892413 |
| 19 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.81784162 |
| 20 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.73265309 |
| 21 | UTX_26944678_Chip-Seq_JUKART_Human | 1.70571875 |
| 22 | VDR_21846776_ChIP-Seq_THP-1_Human | 1.69480053 |
| 23 | GATA3_27048872_Chip-Seq_THYMUS_Human | 1.64841491 |
| 24 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 1.57485388 |
| 25 | MAF_26560356_Chip-Seq_TH1_Human | 1.57128992 |
| 26 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 1.54170191 |
| 27 | MYB_26560356_Chip-Seq_TH1_Human | 1.49960706 |
| 28 | MAF_26560356_Chip-Seq_TH2_Human | 1.49315523 |
| 29 | BCL6_27268052_Chip-Seq_Bcells_Human | 1.47543372 |
| 30 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.46578291 |
| 31 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 1.43993226 |
| 32 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.43285908 |
| 33 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.42384516 |
| 34 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.40066030 |
| 35 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 1.39418152 |
| 36 | REST_21632747_ChIP-Seq_MESCs_Mouse | 1.38789363 |
| 37 | SPI1_23127762_ChIP-Seq_K562_Human | 1.37691100 |
| 38 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.36312922 |
| 39 | GATA3_26560356_Chip-Seq_TH2_Human | 1.36147832 |
| 40 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.35519546 |
| 41 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.29830425 |
| 42 | MYC_22102868_ChIP-Seq_BL_Human | 1.27533124 |
| 43 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.27078493 |
| 44 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 1.25709280 |
| 45 | EBNA2_21746931_ChIP-Seq_IB4-LCL_Human | 1.24694241 |
| 46 | VDR_20736230_ChIP-Seq_LYMPHOBLASTOID_Human | 1.23258833 |
| 47 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.22431838 |
| 48 | BCOR_27268052_Chip-Seq_Bcells_Human | 1.22336080 |
| 49 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 1.18221941 |
| 50 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.17948216 |
| 51 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.16942371 |
| 52 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.16841135 |
| 53 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.16068835 |
| 54 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.16012492 |
| 55 | HOXA2_22223247_ChIP-Seq_E11.5_EMBRYO_Mouse | 1.15761225 |
| 56 | REST_18959480_ChIP-ChIP_MESCs_Mouse | 1.14971147 |
| 57 | VDR_22108803_ChIP-Seq_LS180_Human | 1.11488870 |
| 58 | IGF1R_20145208_ChIP-Seq_DFB_Human | 1.11287976 |
| 59 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.09827071 |
| 60 | P300_27268052_Chip-Seq_Bcells_Human | 1.06416582 |
| 61 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.05827862 |
| 62 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 1.04564729 |
| 63 | OCT4_19829295_ChIP-Seq_ESCs_Human | 1.03271503 |
| 64 | RUNX1_22897851_ChIP-Seq_JUKARTE6-1_Human | 1.03094956 |
| 65 | GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.02718819 |
| 66 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.02514861 |
| 67 | ERA_21632823_ChIP-Seq_H3396_Human | 1.02400249 |
| 68 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 1.01944943 |
| 69 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 0.99122353 |
| 70 | NANOG_20526341_ChIP-Seq_ESCs_Human | 0.98205859 |
| 71 | PBX1_22567123_ChIP-ChIP_OVCAR3_Human | 0.96855514 |
| 72 | TCF7_22412390_ChIP-Seq_EML_Mouse | 0.96521173 |
| 73 | ETV2_25802403_ChIP-Seq_MESCs_Mouse | 0.96437006 |
| 74 | P68_20966046_ChIP-Seq_HELA_Human | 0.96191582 |
| 75 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 0.95914408 |
| 76 | SMAD2/3_21741376_ChIP-Seq_ESCs_Human | 0.95532226 |
| 77 | RBPJ_21746931_ChIP-Seq_IB4-LCL_Human | 0.94820587 |
| 78 | E2F1_20622854_ChIP-Seq_HELA_Human | 0.94288650 |
| 79 | OCT4_20526341_ChIP-Seq_ESCs_Human | 0.93826624 |
| 80 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 0.93736706 |
| 81 | EWS-ERG_20517297_ChIP-Seq_CADO-ES1_Human | 0.93031640 |
| 82 | CIITA_25753668_ChIP-Seq_RAJI_Human | 0.92982286 |
| 83 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 0.92626822 |
| 84 | MYC_19829295_ChIP-Seq_ESCs_Human | 0.92376504 |
| 85 | RUNX1_17652178_ChIP-ChIP_JURKAT_Human | 0.91762954 |
| 86 | STAT1_20625510_ChIP-Seq_HELA_Human | 0.90895224 |
| 87 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.89797927 |
| 88 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 0.89418647 |
| 89 | RAC3_21632823_ChIP-Seq_H3396_Human | 0.88071938 |
| 90 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 0.87537317 |
| 91 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 0.86602594 |
| 92 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 0.86596120 |
| 93 | GATA3_21878914_ChIP-Seq_MCF-7_Human | 0.86418080 |
| 94 | SMRT_27268052_Chip-Seq_Bcells_Human | 0.86387522 |
| 95 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 0.86332435 |
| 96 | PHF8_20622854_ChIP-Seq_HELA_Human | 0.85496335 |
| 97 | GATA3_26560356_Chip-Seq_TH1_Human | 0.84969330 |
| 98 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 0.84777925 |
| 99 | TAF2_19829295_ChIP-Seq_ESCs_Human | 0.84749613 |
| 100 | CHD7_19251738_ChIP-ChIP_MESCs_Mouse | 0.84679131 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0003724_increased_susceptibility_to | 3.29496055 |
| 2 | MP0003763_abnormal_thymus_physiology | 2.83104664 |
| 3 | MP0005671_abnormal_response_to | 2.74771895 |
| 4 | MP0001800_abnormal_humoral_immune | 2.54794066 |
| 5 | MP0001835_abnormal_antigen_presentation | 2.43181879 |
| 6 | MP0003436_decreased_susceptibility_to | 2.39358445 |
| 7 | MP0001790_abnormal_immune_system | 2.39093219 |
| 8 | MP0005387_immune_system_phenotype | 2.39093219 |
| 9 | MP0000685_abnormal_immune_system | 2.30006284 |
| 10 | MP0005000_abnormal_immune_tolerance | 2.17256956 |
| 11 | MP0002723_abnormal_immune_serum | 2.12576292 |
| 12 | MP0003183_abnormal_peptide_metabolism | 2.08714206 |
| 13 | MP0002420_abnormal_adaptive_immunity | 2.08544756 |
| 14 | MP0001819_abnormal_immune_cell | 2.05658179 |
| 15 | MP0005025_abnormal_response_to | 2.02594226 |
| 16 | MP0002138_abnormal_hepatobiliary_system | 2.01158695 |
| 17 | MP0005310_abnormal_salivary_gland | 1.95563806 |
| 18 | MP0002452_abnormal_antigen_presenting | 1.93842266 |
| 19 | MP0003787_abnormal_imprinting | 1.91329512 |
| 20 | MP0001501_abnormal_sleep_pattern | 1.87436543 |
| 21 | MP0001986_abnormal_taste_sensitivity | 1.83216086 |
| 22 | MP0003303_peritoneal_inflammation | 1.83145512 |
| 23 | MP0000465_gastrointestinal_hemorrhage | 1.77427051 |
| 24 | MP0002419_abnormal_innate_immunity | 1.73873249 |
| 25 | MP0009785_altered_susceptibility_to | 1.73658938 |
| 26 | MP0002148_abnormal_hypersensitivity_rea | 1.72491568 |
| 27 | MP0002277_abnormal_respiratory_mucosa | 1.71570825 |
| 28 | MP0009278_abnormal_bone_marrow | 1.69667104 |
| 29 | MP0009333_abnormal_splenocyte_physiolog | 1.68527486 |
| 30 | MP0003866_abnormal_defecation | 1.66818148 |
| 31 | MP0000716_abnormal_immune_system | 1.66087171 |
| 32 | MP0002398_abnormal_bone_marrow | 1.65854974 |
| 33 | MP0001873_stomach_inflammation | 1.61079085 |
| 34 | MP0002396_abnormal_hematopoietic_system | 1.57732394 |
| 35 | MP0006082_CNS_inflammation | 1.51023141 |
| 36 | MP0010155_abnormal_intestine_physiology | 1.48393110 |
| 37 | MP0000689_abnormal_spleen_morphology | 1.47542524 |
| 38 | MP0002653_abnormal_ependyma_morphology | 1.47262921 |
| 39 | MP0000703_abnormal_thymus_morphology | 1.42464524 |
| 40 | MP0002405_respiratory_system_inflammati | 1.40888397 |
| 41 | MP0005464_abnormal_platelet_physiology | 1.37603663 |
| 42 | MP0002722_abnormal_immune_system | 1.35708722 |
| 43 | MP0008877_abnormal_DNA_methylation | 1.34457884 |
| 44 | MP0003646_muscle_fatigue | 1.29280367 |
| 45 | MP0004142_abnormal_muscle_tone | 1.28737333 |
| 46 | MP0005075_abnormal_melanosome_morpholog | 1.28615911 |
| 47 | MP0004381_abnormal_hair_follicle | 1.28087078 |
| 48 | MP0003172_abnormal_lysosome_physiology | 1.26888381 |
| 49 | MP0001845_abnormal_inflammatory_respons | 1.26359910 |
| 50 | MP0002928_abnormal_bile_duct | 1.23550071 |
| 51 | MP0009764_decreased_sensitivity_to | 1.23367207 |
| 52 | MP0002429_abnormal_blood_cell | 1.22196308 |
| 53 | MP0001968_abnormal_touch/_nociception | 1.17621701 |
| 54 | MP0004043_abnormal_pH_regulation | 1.17575204 |
| 55 | MP0008995_early_reproductive_senescence | 1.17268880 |
| 56 | MP0005535_abnormal_body_temperature | 1.16596173 |
| 57 | MP0002822_catalepsy | 1.14798127 |
| 58 | MP0005646_abnormal_pituitary_gland | 1.10268931 |
| 59 | MP0001905_abnormal_dopamine_level | 1.10252199 |
| 60 | MP0002064_seizures | 1.07881730 |
| 61 | MP0009745_abnormal_behavioral_response | 1.05372127 |
| 62 | MP0008469_abnormal_protein_level | 1.04496620 |
| 63 | MP0001663_abnormal_digestive_system | 1.04185655 |
| 64 | MP0001533_abnormal_skeleton_physiology | 1.02301524 |
| 65 | MP0002693_abnormal_pancreas_physiology | 1.00829289 |
| 66 | MP0002876_abnormal_thyroid_physiology | 0.99859884 |
| 67 | MP0005397_hematopoietic_system_phenotyp | 0.99818943 |
| 68 | MP0001545_abnormal_hematopoietic_system | 0.99818943 |
| 69 | MP0003880_abnormal_central_pattern | 0.95803954 |
| 70 | MP0006276_abnormal_autonomic_nervous | 0.95048063 |
| 71 | MP0002735_abnormal_chemical_nociception | 0.92236549 |
| 72 | MP0008961_abnormal_basal_metabolism | 0.91027857 |
| 73 | MP0005645_abnormal_hypothalamus_physiol | 0.89515923 |
| 74 | MP0004130_abnormal_muscle_cell | 0.88980156 |
| 75 | MP0001764_abnormal_homeostasis | 0.88562334 |
| 76 | MP0002272_abnormal_nervous_system | 0.88194507 |
| 77 | MP0002572_abnormal_emotion/affect_behav | 0.87090473 |
| 78 | MP0001970_abnormal_pain_threshold | 0.86053670 |
| 79 | MP0008872_abnormal_physiological_respon | 0.85352567 |
| 80 | MP0002006_tumorigenesis | 0.83892060 |
| 81 | MP0009046_muscle_twitch | 0.83680902 |
| 82 | MP0005084_abnormal_gallbladder_morpholo | 0.82949998 |
| 83 | MP0001486_abnormal_startle_reflex | 0.81179981 |
| 84 | MP0002733_abnormal_thermal_nociception | 0.80386836 |
| 85 | MP0003879_abnormal_hair_cell | 0.79949619 |
| 86 | MP0003635_abnormal_synaptic_transmissio | 0.78533805 |
| 87 | MP0005551_abnormal_eye_electrophysiolog | 0.75845722 |
| 88 | MP0001765_abnormal_ion_homeostasis | 0.75774610 |
| 89 | MP0003878_abnormal_ear_physiology | 0.75344082 |
| 90 | MP0005377_hearing/vestibular/ear_phenot | 0.75344082 |
| 91 | MP0004947_skin_inflammation | 0.75166620 |
| 92 | MP0001919_abnormal_reproductive_system | 0.75088299 |
| 93 | MP0005448_abnormal_energy_balance | 0.74140442 |
| 94 | MP0002638_abnormal_pupillary_reflex | 0.72573258 |
| 95 | MP0002063_abnormal_learning/memory/cond | 0.72367582 |
| 96 | MP0005174_abnormal_tail_pigmentation | 0.72278225 |
| 97 | MP0003195_calcinosis | 0.70640971 |
| 98 | MP0000015_abnormal_ear_pigmentation | 0.70247143 |
| 99 | MP0001485_abnormal_pinna_reflex | 0.68228231 |
| 100 | MP0002166_altered_tumor_susceptibility | 0.66272923 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Stomatitis (HP:0010280) | 4.98746164 |
| 2 | Myositis (HP:0100614) | 4.52669125 |
| 3 | Elevated erythrocyte sedimentation rate (HP:0003565) | 4.37126400 |
| 4 | Panhypogammaglobulinemia (HP:0003139) | 4.26113894 |
| 5 | Retrobulbar optic neuritis (HP:0100654) | 4.24511174 |
| 6 | Optic neuritis (HP:0100653) | 4.24511174 |
| 7 | Orchitis (HP:0100796) | 4.08117405 |
| 8 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 4.00254906 |
| 9 | Recurrent fungal infections (HP:0002841) | 3.80126389 |
| 10 | Eczematoid dermatitis (HP:0000976) | 3.69777207 |
| 11 | Recurrent cutaneous fungal infections (HP:0011370) | 3.42441647 |
| 12 | Chronic mucocutaneous candidiasis (HP:0002728) | 3.42441647 |
| 13 | Encephalitis (HP:0002383) | 3.36730833 |
| 14 | Severe combined immunodeficiency (HP:0004430) | 3.10800775 |
| 15 | Meningitis (HP:0001287) | 3.04132739 |
| 16 | Keratoconjunctivitis (HP:0001096) | 3.02225245 |
| 17 | Pustule (HP:0200039) | 2.93668432 |
| 18 | Absent rod-and cone-mediated responses on ERG (HP:0007688) | 2.91163772 |
| 19 | Keratoconjunctivitis sicca (HP:0001097) | 2.78837540 |
| 20 | Congenital stationary night blindness (HP:0007642) | 2.77084081 |
| 21 | Vasculitis (HP:0002633) | 2.71746618 |
| 22 | Abnormal rod and cone electroretinograms (HP:0008323) | 2.69776430 |
| 23 | Stomach cancer (HP:0012126) | 2.67798042 |
| 24 | Abnormality of T cells (HP:0002843) | 2.66749147 |
| 25 | Mediastinal lymphadenopathy (HP:0100721) | 2.66208990 |
| 26 | Attenuation of retinal blood vessels (HP:0007843) | 2.61297735 |
| 27 | Abnormality of T cell physiology (HP:0011840) | 2.57717268 |
| 28 | Hemoptysis (HP:0002105) | 2.57308901 |
| 29 | Abnormality of B cell number (HP:0010975) | 2.56948782 |
| 30 | Granulocytopenia (HP:0001913) | 2.51105000 |
| 31 | Episodic fever (HP:0001954) | 2.50417380 |
| 32 | Recurrent abscess formation (HP:0002722) | 2.49088964 |
| 33 | Recurrent bacterial skin infections (HP:0005406) | 2.47135831 |
| 34 | Papilledema (HP:0001085) | 2.45363267 |
| 35 | Recurrent skin infections (HP:0001581) | 2.43433185 |
| 36 | Clumsiness (HP:0002312) | 2.42790410 |
| 37 | Agammaglobulinemia (HP:0004432) | 2.42130350 |
| 38 | Leukocytosis (HP:0001974) | 2.41088466 |
| 39 | Abnormality of eosinophils (HP:0001879) | 2.37629230 |
| 40 | Pulmonary infiltrates (HP:0002113) | 2.37549657 |
| 41 | Decreased circulating renin level (HP:0003351) | 2.36489216 |
| 42 | Increased IgM level (HP:0003496) | 2.32068453 |
| 43 | Obstructive lung disease (HP:0006536) | 2.31370535 |
| 44 | Chronic obstructive pulmonary disease (HP:0006510) | 2.31370535 |
| 45 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 2.29770318 |
| 46 | Eosinophilia (HP:0001880) | 2.25738316 |
| 47 | Recurrent viral infections (HP:0004429) | 2.25042879 |
| 48 | IgG deficiency (HP:0004315) | 2.24532530 |
| 49 | Increased IgE level (HP:0003212) | 2.23374229 |
| 50 | Abnormality of macrophages (HP:0004311) | 2.22453222 |
| 51 | T lymphocytopenia (HP:0005403) | 2.22125685 |
| 52 | Abnormality of T cell number (HP:0011839) | 2.20991151 |
| 53 | Decreased central vision (HP:0007663) | 2.19723411 |
| 54 | Hypochromic microcytic anemia (HP:0004840) | 2.17933858 |
| 55 | Prolonged bleeding time (HP:0003010) | 2.17500220 |
| 56 | Pulmonary embolism (HP:0002204) | 2.15279867 |
| 57 | B lymphocytopenia (HP:0010976) | 2.13872885 |
| 58 | Combined immunodeficiency (HP:0005387) | 2.09500340 |
| 59 | Inflammation of the large intestine (HP:0002037) | 2.07127764 |
| 60 | Large for gestational age (HP:0001520) | 2.05546803 |
| 61 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.02688435 |
| 62 | Gastrointestinal inflammation (HP:0004386) | 2.02652740 |
| 63 | Lymphopenia (HP:0001888) | 2.01330838 |
| 64 | Abnormality of the pleura (HP:0002103) | 2.01145854 |
| 65 | Hypochromic anemia (HP:0001931) | 1.99585727 |
| 66 | Spontaneous hematomas (HP:0007420) | 1.99163185 |
| 67 | Chest pain (HP:0100749) | 1.98885550 |
| 68 | Chronic sinusitis (HP:0011109) | 1.97492223 |
| 69 | Recurrent bronchitis (HP:0002837) | 1.96649115 |
| 70 | Thyroiditis (HP:0100646) | 1.95002689 |
| 71 | Hyperventilation (HP:0002883) | 1.94497779 |
| 72 | Gastrointestinal infarctions (HP:0005244) | 1.93745046 |
| 73 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 1.93312880 |
| 74 | Ketosis (HP:0001946) | 1.92286439 |
| 75 | Autoimmune hemolytic anemia (HP:0001890) | 1.91584435 |
| 76 | IgM deficiency (HP:0002850) | 1.91381991 |
| 77 | Alveolar cell carcinoma (HP:0006519) | 1.90249032 |
| 78 | Focal motor seizures (HP:0011153) | 1.89312053 |
| 79 | Vertigo (HP:0002321) | 1.88774430 |
| 80 | Autoimmune thrombocytopenia (HP:0001973) | 1.88099487 |
| 81 | Abolished electroretinogram (ERG) (HP:0000550) | 1.87699726 |
| 82 | Progressive cerebellar ataxia (HP:0002073) | 1.86677001 |
| 83 | Anorexia (HP:0002039) | 1.85307572 |
| 84 | Pigmentary retinal degeneration (HP:0001146) | 1.84400933 |
| 85 | Arterial thrombosis (HP:0004420) | 1.82908580 |
| 86 | Keratitis (HP:0000491) | 1.82398536 |
| 87 | Chronic diarrhea (HP:0002028) | 1.82110702 |
| 88 | Recurrent sinusitis (HP:0011108) | 1.82082209 |
| 89 | Neurodegeneration (HP:0002180) | 1.81395811 |
| 90 | Chronic hepatic failure (HP:0100626) | 1.81128895 |
| 91 | Diplopia (HP:0000651) | 1.80136780 |
| 92 | Abnormality of binocular vision (HP:0011514) | 1.80136780 |
| 93 | Microcytic anemia (HP:0001935) | 1.79859755 |
| 94 | Papilloma (HP:0012740) | 1.79730340 |
| 95 | Verrucae (HP:0200043) | 1.79730340 |
| 96 | Congenital sensorineural hearing impairment (HP:0008527) | 1.75983735 |
| 97 | Abnormal drinking behavior (HP:0030082) | 1.74147581 |
| 98 | Polydipsia (HP:0001959) | 1.74147581 |
| 99 | Visual hallucinations (HP:0002367) | 1.72504523 |
| 100 | Abnormality of cells of the lymphoid lineage (HP:0012140) | 1.72411975 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MAP4K1 | 4.57747835 |
| 2 | FRK | 3.21027975 |
| 3 | TAOK3 | 3.09670546 |
| 4 | TXK | 2.81057231 |
| 5 | TNK2 | 2.48882366 |
| 6 | RIPK4 | 2.48721504 |
| 7 | FES | 2.43006511 |
| 8 | GRK6 | 2.07143045 |
| 9 | PINK1 | 2.01262264 |
| 10 | BTK | 1.91632386 |
| 11 | ITK | 1.85979501 |
| 12 | SYK | 1.80911937 |
| 13 | IRAK4 | 1.79915168 |
| 14 | SIK2 | 1.70907111 |
| 15 | MAP4K2 | 1.65775002 |
| 16 | CAMKK2 | 1.57380043 |
| 17 | WNK3 | 1.51064113 |
| 18 | CDK19 | 1.50720084 |
| 19 | IKBKE | 1.44769617 |
| 20 | BLK | 1.42713466 |
| 21 | TYK2 | 1.42333509 |
| 22 | ZAP70 | 1.41563924 |
| 23 | KIT | 1.39735724 |
| 24 | MAP2K3 | 1.39377527 |
| 25 | LCK | 1.33943855 |
| 26 | PASK | 1.33911270 |
| 27 | IKBKB | 1.33348660 |
| 28 | CAMKK1 | 1.32044514 |
| 29 | JAK3 | 1.31688080 |
| 30 | TEC | 1.31677535 |
| 31 | LYN | 1.22703519 |
| 32 | INSRR | 1.22416661 |
| 33 | HCK | 1.22341960 |
| 34 | MAP3K11 | 1.20141521 |
| 35 | MAPK13 | 1.19028107 |
| 36 | ADRBK2 | 1.13932645 |
| 37 | CSF1R | 1.12654660 |
| 38 | TBK1 | 1.10543235 |
| 39 | CSK | 1.10337986 |
| 40 | TAOK1 | 1.08524316 |
| 41 | NLK | 1.06463119 |
| 42 | IRAK2 | 1.06160467 |
| 43 | PRKCQ | 1.05838830 |
| 44 | DAPK2 | 1.03684059 |
| 45 | ERN1 | 1.03180771 |
| 46 | MAP2K6 | 1.02706020 |
| 47 | DYRK1B | 1.01775248 |
| 48 | MAPK12 | 1.00364989 |
| 49 | SIK3 | 0.96648127 |
| 50 | PRKD2 | 0.95553226 |
| 51 | MARK3 | 0.92180983 |
| 52 | IRAK1 | 0.91584451 |
| 53 | BCKDK | 0.91339242 |
| 54 | TLK1 | 0.90207493 |
| 55 | MARK2 | 0.88990562 |
| 56 | PRPF4B | 0.86178565 |
| 57 | ZAK | 0.84344196 |
| 58 | MAP3K1 | 0.80321685 |
| 59 | JAK2 | 0.78890080 |
| 60 | ACVR1B | 0.78089919 |
| 61 | PRKCH | 0.77123176 |
| 62 | OXSR1 | 0.76790185 |
| 63 | PDK1 | 0.75523551 |
| 64 | PIK3CA | 0.74599125 |
| 65 | MATK | 0.74328187 |
| 66 | MAP3K7 | 0.72401325 |
| 67 | FGFR3 | 0.71923529 |
| 68 | STK11 | 0.70834024 |
| 69 | MAP3K14 | 0.68827892 |
| 70 | JAK1 | 0.66578525 |
| 71 | HIPK2 | 0.65791872 |
| 72 | EPHA3 | 0.65072693 |
| 73 | MAP2K2 | 0.63822640 |
| 74 | NTRK2 | 0.62617875 |
| 75 | TESK2 | 0.62449749 |
| 76 | RPS6KA6 | 0.62279372 |
| 77 | MAPK7 | 0.61903054 |
| 78 | PTK2B | 0.61393017 |
| 79 | PIM1 | 0.60282021 |
| 80 | CHUK | 0.59489047 |
| 81 | UHMK1 | 0.57814966 |
| 82 | EPHB1 | 0.56315318 |
| 83 | NTRK3 | 0.54927822 |
| 84 | MAP2K4 | 0.53268039 |
| 85 | ADRBK1 | 0.49819364 |
| 86 | FGFR2 | 0.49767590 |
| 87 | MAP2K7 | 0.49472054 |
| 88 | PRKCZ | 0.47542289 |
| 89 | CAMK1 | 0.47085297 |
| 90 | MAP3K4 | 0.45836720 |
| 91 | MAPK15 | 0.44668591 |
| 92 | PHKG2 | 0.44210452 |
| 93 | PHKG1 | 0.44210452 |
| 94 | GRK7 | 0.44136043 |
| 95 | CAMK4 | 0.44080073 |
| 96 | RPS6KC1 | 0.42962220 |
| 97 | RPS6KL1 | 0.42962220 |
| 98 | OBSCN | 0.41313695 |
| 99 | FYN | 0.40605222 |
| 100 | GRK1 | 0.40443242 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Primary immunodeficiency_Homo sapiens_hsa05340 | 3.81516297 |
| 2 | Allograft rejection_Homo sapiens_hsa05330 | 2.70489451 |
| 3 | Graft-versus-host disease_Homo sapiens_hsa05332 | 2.63318645 |
| 4 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 2.62904452 |
| 5 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 2.48498439 |
| 6 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 2.47273324 |
| 7 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 2.23970276 |
| 8 | Asthma_Homo sapiens_hsa05310 | 2.07112366 |
| 9 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 2.03601755 |
| 10 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.78595116 |
| 11 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 1.78131752 |
| 12 | Leishmaniasis_Homo sapiens_hsa05140 | 1.76580546 |
| 13 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.70178564 |
| 14 | Osteoclast differentiation_Homo sapiens_hsa04380 | 1.67611605 |
| 15 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 1.64740688 |
| 16 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.58110636 |
| 17 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.56029273 |
| 18 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 1.55285482 |
| 19 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.49365263 |
| 20 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 1.48559435 |
| 21 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.44286816 |
| 22 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 1.44166300 |
| 23 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.32049838 |
| 24 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.30925511 |
| 25 | Tuberculosis_Homo sapiens_hsa05152 | 1.29356530 |
| 26 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.25586724 |
| 27 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 1.25093119 |
| 28 | Morphine addiction_Homo sapiens_hsa05032 | 1.24094126 |
| 29 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 1.23000197 |
| 30 | Phototransduction_Homo sapiens_hsa04744 | 1.22964769 |
| 31 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 1.20888524 |
| 32 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 1.20049121 |
| 33 | Measles_Homo sapiens_hsa05162 | 1.18400003 |
| 34 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 1.16914666 |
| 35 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.10837565 |
| 36 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 1.09601041 |
| 37 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.04975433 |
| 38 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.04775529 |
| 39 | Ether lipid metabolism_Homo sapiens_hsa00565 | 1.01910231 |
| 40 | Other glycan degradation_Homo sapiens_hsa00511 | 1.00924512 |
| 41 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.98639328 |
| 42 | ABC transporters_Homo sapiens_hsa02010 | 0.96646521 |
| 43 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.94640990 |
| 44 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.93487037 |
| 45 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 0.93340319 |
| 46 | Calcium signaling pathway_Homo sapiens_hsa04020 | 0.89194433 |
| 47 | Circadian entrainment_Homo sapiens_hsa04713 | 0.88581395 |
| 48 | Viral myocarditis_Homo sapiens_hsa05416 | 0.88455152 |
| 49 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.87547260 |
| 50 | Nicotine addiction_Homo sapiens_hsa05033 | 0.86733536 |
| 51 | Platelet activation_Homo sapiens_hsa04611 | 0.86356670 |
| 52 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.85506686 |
| 53 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.85091501 |
| 54 | Olfactory transduction_Homo sapiens_hsa04740 | 0.84066301 |
| 55 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.81802988 |
| 56 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.81580080 |
| 57 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.81348126 |
| 58 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.79408658 |
| 59 | Renin secretion_Homo sapiens_hsa04924 | 0.78748126 |
| 60 | Taste transduction_Homo sapiens_hsa04742 | 0.78608288 |
| 61 | Salivary secretion_Homo sapiens_hsa04970 | 0.78024062 |
| 62 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.77243557 |
| 63 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 0.76780706 |
| 64 | Cholinergic synapse_Homo sapiens_hsa04725 | 0.74901583 |
| 65 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 0.73570157 |
| 66 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 0.72725952 |
| 67 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.72181225 |
| 68 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.71912203 |
| 69 | Butanoate metabolism_Homo sapiens_hsa00650 | 0.68907521 |
| 70 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.68789397 |
| 71 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 0.67776568 |
| 72 | Amphetamine addiction_Homo sapiens_hsa05031 | 0.67323683 |
| 73 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.67204309 |
| 74 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 0.66623424 |
| 75 | Insulin secretion_Homo sapiens_hsa04911 | 0.66493779 |
| 76 | Serotonergic synapse_Homo sapiens_hsa04726 | 0.66159254 |
| 77 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.65976220 |
| 78 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.65648566 |
| 79 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.64720525 |
| 80 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.58146532 |
| 81 | Influenza A_Homo sapiens_hsa05164 | 0.58027269 |
| 82 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.56278235 |
| 83 | GABAergic synapse_Homo sapiens_hsa04727 | 0.56081035 |
| 84 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.55902981 |
| 85 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.54626784 |
| 86 | Cocaine addiction_Homo sapiens_hsa05030 | 0.54523946 |
| 87 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.53816620 |
| 88 | Malaria_Homo sapiens_hsa05144 | 0.52856213 |
| 89 | Glutamatergic synapse_Homo sapiens_hsa04724 | 0.51704171 |
| 90 | cAMP signaling pathway_Homo sapiens_hsa04024 | 0.50561390 |
| 91 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.46903241 |
| 92 | Gastric acid secretion_Homo sapiens_hsa04971 | 0.46856913 |
| 93 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.46465679 |
| 94 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.45748711 |
| 95 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.45600366 |
| 96 | Dopaminergic synapse_Homo sapiens_hsa04728 | 0.45218769 |
| 97 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.44426539 |
| 98 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.43174035 |
| 99 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.42728068 |
| 100 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.42456882 |

